鹏华中证医药指数(LOF)C(010366)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
3,662,840.55 |
-14,779,901.10 |
-23,382,027.15 |
-12,386,531.26 |
| 利息合计 |
12,358.58 |
26,336.51 |
13,074.35 |
31,458.38 |
| 其中：存款利息收入 |
12,358.58 |
26,336.51 |
13,074.35 |
31,458.38 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-5,064,168.78 |
-10,033,208.06 |
-4,412,743.37 |
-5,732,824.70 |
| 其中：股票投资收益 |
-6,097,543.42 |
-12,118,490.05 |
-5,591,278.62 |
-7,356,472.59 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
1,033,374.64 |
2,085,281.99 |
1,178,535.25 |
1,623,647.89 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
8,668,973.39 |
-4,849,349.20 |
-19,006,309.51 |
-6,734,840.85 |
| 其他收入 |
45,677.36 |
76,319.65 |
23,951.38 |
49,675.91 |
| 费用 |
588,604.51 |
1,386,145.60 |
699,321.46 |
1,544,328.47 |
| 管理人报酬 |
414,049.39 |
842,188.52 |
422,516.24 |
962,717.02 |
| 基金托管费 |
82,809.81 |
168,437.75 |
84,503.28 |
192,543.30 |
| 销售服务费 |
13,908.20 |
28,013.46 |
13,773.08 |
30,829.74 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
77,837.11 |
347,505.87 |
178,528.86 |
358,238.41 |
| 利润总额 |
3,074,236.04 |
-16,166,046.70 |
-24,081,348.61 |
-13,930,859.73 |
微信公众号
证券之星APP
基本资料
